Skip to NavigationSkip to content

News

OxyContin drugmaker Purdue Pharma is exploring the option of filing for bankruptcy. The news comes as the Connecticut-based firm faces thousands of...
AbbVie’s interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab) has secured recommendation from the EMA’s Committee for Medicinal Products for...
As part of an effort to promote low cost medicines the Indian government has announced plans to colour code generic drugs.
Canadian physicians have called on the federal government to review its funding for a programme which sends volunteer homeopaths to Honduras.
Biogen has announced it has inked an agreement to acquire clinical-stage gene therapy firm Nightstar for a total value of $800 million, which...
The head of NHS England has warned that ‘vaccination deniers’ are increasing their influence on social media through ’fake news’.
British scientist develops technology able to deliver drugs directly into the brain More than 40% of GPs intend to quit within five years Rise in...
US Senator Bernie Sanders has called on regulators to allow pharmacies and manufacturers to distribute generic versions of Catalyst Pharmaceuticals...
Edinburgh-based drug discovery firm AdoRx therapeutics has signed a deal with US healthcare conglomerate Johnson & Johnson to develop novel...
The Philippine Justice Ministry has said it has found probably cause to charge officials working for French drugmaker Sanofi over the death and...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches